Hem/Onc Roundup: Cancer’s Long-Term Impact, Lung Cancer Immunotherapy, and more
Lung Cancer Patients with a Specific Human Leukocyte Antigen More [...]
POCN Hem/Onc
Hem/Onc Roundup: Cancer’s Long-Term Impact, Lung Cancer Immunotherapy, and more
| Categories: hematology-oncology, pocn-hem-onc
Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy A new study shows that lung cancer patients with a […]
Brian Jonas, MD, Discusses FDA Approval of Venclexta® in Combination for the Treatment of Newly Diagnosed AML
Brian Jonas, MD, PhD, FACP sat down with DocWire News [...]
CNS Pharmaceuticals Announces FDA Filing for Investigational New Drug to Treat Glioblastoma
CNS Pharmaceuticals announced this week that it has submitted for [...]
Persistent Poverty Correlated with Increased Cancer Mortality
Cancer patients living in counties with persistent poverty may be [...]
